Connor, Clark & Lunn Investment Management (CC&L)’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $935K | Sell |
|
|||||
|
2024
Q4 | $2.5M | Sell |
|
|||||
|
2024
Q3 | $4.06M | Sell |
|
|||||
|
2024
Q2 | $4.16M | Buy |
|
|||||
|
2024
Q1 | $3.89M | Buy |
|
|||||
|
2023
Q4 | $2.55M | Buy |
|
|||||
|
2023
Q3 | $847K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $262K | Sell |
|
|||||
|
2016
Q2 | $258K | Sell |
|
|||||
|
2016
Q1 | $491K | Sell |
|
|||||
|
2015
Q4 | $699K | Buy |
|
|||||
|
2015
Q3 | $430K | Buy |
|